Table 4.
Anthropometric measurements and laboratory findings according to the metabolic category.
| Parameter | pre-MetS n = 40 Me (Q1–Q3) |
MetS n = 47 Me (Q1–Q3) |
MHO n = 18 Me (Q1–Q3) |
H | p |
|---|---|---|---|---|---|
| Age (years) | 30 (24.5–39.5) | 38 (27–45) | 40 (30–46) | 2.81 | 0.25 |
| BMI | 35.5 (32–39) | 37 (34–40) | 32.5 (31–35) | 15.82 | <0.001 |
| WC (cm) | 99.5 (95–110) | 108 (100–120) | 96 (91–101) | 22.47 | <0.001 |
| TC (mg/dL) | 181 (165.5–205) | 202.5 (179–226) | 177 (153–203) | 8.11 | 0.02 |
| TG (mg/dL) | 125.5 (93.5–158) | 186 (134–224) | 83.5 (71–88) | 33.27 | <0.001 |
| HDL (mg/dL) | 50.5 (44–64) | 45.5 (37–57) | 62 (53–70) | 14.32 | 0.001 |
| LDL (mg/dL) | 115.5 (106–138.5) | 132 (116–161) | 108 (89–141) | 9.75 | 0.01 |
| VLDL (mg/dL) | 25.1 (18.7–31.6) | 36.6 (26.6–44.8) | 16.7 (14.2–17.6) | 30.58 | <0.001 |
| ALT (U/I) | 23.5 (17–33.5) | 33 (19–52) | 18 (14–22) | 13.12 | 0.001 |
| AST (U/I) | 21.5 (18–26.5) | 21 (17–31) | 18 (15–22) | 6.96 | 0.03 |
| GGTP (U/I) | 22 (15–36) | 33 (23.5–51.5) | 16 (11–23) | 19.57 | <0.001 |
| G-0 (mg/dL) | 95 (92–100) | 99 (94–108) | 94 (88–98) | 9.54 | 0.01 |
| G-120 (mg/dL) | 109 (88–119) | 126 (107–165) | 102.5 (93–113) | 14.74 | <0.001 |
| HOMA-IR | 4.5 (3.6–5.75) | 6.75 (4.4–9.4) | 2.95 (2.4–3.95) | 21.98 | <0.001 |
H-ANOVA Kruskal–Wallis test, a comparison between 3 groups as a median (Me) and an interquartile range (Q1–Q3). A p-value in bold type marks a significant difference (p < 0.05). BMI: body mass index; WC: waist circumference; TC: total cholesterol; TG: triglycerides; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; ALT: alanine transaminase; AST: aspartate transaminase; GGTP: gamma-glutamyl transferase; HOMA IR: Homeostatic Model Assessment for Insulin Resistance.